Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- bs-0849R - Provider product page
- Provider
- Bioss
- Proper citation
- Bioss Cat#bs-0849R, RRID:AB_10856740
- Product name
- APOA1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- KLH conjugated synthetic peptide derived from human APOA1
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100ul
- Concentration
- 1ug/ul
- Storage
- Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
Submitted references Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage.
Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl4-induced acute liver injury and LPS-treated RAW264.7 cells.
LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning.
Zhao X, Ting SM, Liu CH, Sun G, Kruzel M, Roy-O'Reilly M, Aronowski J
Nature communications 2017 Sep 19;8(1):602
Nature communications 2017 Sep 19;8(1):602
Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl4-induced acute liver injury and LPS-treated RAW264.7 cells.
Chen X, Ding HW, Li HD, Huang HM, Li XF, Yang Y, Zhang YL, Pan XY, Huang C, Meng XM, Li J
Toxicology letters 2017 May 15;274:51-63
Toxicology letters 2017 May 15;274:51-63
LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
Wang YY, Wu ZY, Wang GC, Liu K, Niu XB, Gu S, Meng JS
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Nov;37(11):14553-14563
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Nov;37(11):14553-14563
Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning.
Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Lamon D, Furber A, Pinet F, Prunier F
PloS one 2013;8(10):e77211
PloS one 2013;8(10):e77211
No comments: Submit comment
No validations: Submit validation data